Metropolitan Life Insurance Company (MetLife)’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-68,816
Closed -$1.26M 2388
2021
Q4
$1.26M Sell
68,816
-1,091
-2% -$19.9K 0.02% 814
2021
Q3
$1.48M Sell
69,907
-2,098
-3% -$44.4K 0.02% 692
2021
Q2
$1.31M Buy
72,005
+7,248
+11% +$132K 0.02% 800
2021
Q1
$1.46M Buy
64,757
+2,878
+5% +$65K 0.02% 711
2020
Q4
$1.24M Sell
61,879
-1,232
-2% -$24.7K 0.02% 747
2020
Q3
$1.54M Sell
63,111
-2,800
-4% -$68.5K 0.03% 519
2020
Q2
$1.56M Sell
65,911
-20,475
-24% -$486K 0.03% 503
2020
Q1
$1.49M Sell
86,386
-4,661
-5% -$80.3K 0.03% 500
2019
Q4
$1.6M Buy
91,047
+582
+0.6% +$10.3K 0.03% 657
2019
Q3
$1.6M Sell
90,465
-10,117
-10% -$179K 0.03% 609
2019
Q2
$2.15M Sell
100,582
-50
-0% -$1.07K 0.04% 495
2019
Q1
$2.4M Sell
100,632
-187
-0.2% -$4.45K 0.04% 396
2018
Q4
$1.98M Buy
100,819
+384
+0.4% +$7.55K 0.04% 426
2018
Q3
$1.78M Buy
100,435
+77,332
+335% +$1.37M 0.03% 590
2018
Q2
$497K Buy
23,103
+1,262
+6% +$27.2K 0.01% 1315
2018
Q1
$484K Buy
21,841
+252
+1% +$5.58K 0.01% 1299
2017
Q4
$656K Sell
21,589
-203
-0.9% -$6.17K 0.01% 1095
2017
Q3
$528K Buy
21,792
+1,112
+5% +$26.9K ﹤0.01% 1658
2017
Q2
$509K Sell
20,680
-134,202
-87% -$3.3M ﹤0.01% 1674
2017
Q1
$3.36M Sell
154,882
-6,542
-4% -$142K 0.02% 780
2016
Q4
$2.41M Sell
161,424
-300
-0.2% -$4.47K 0.02% 906
2016
Q3
$2.07M Sell
161,724
-2,554
-2% -$32.7K 0.02% 944
2016
Q2
$1.28M Buy
164,278
+6,115
+4% +$47.8K 0.01% 1121
2016
Q1
$633K Buy
158,163
+820
+0.5% +$3.28K ﹤0.01% 1443
2015
Q4
$887K Hold
157,343
0.01% 1251
2015
Q3
$883K Buy
157,343
+50,304
+47% +$282K 0.01% 1261
2015
Q2
$402K Sell
107,039
-46,576
-30% -$175K ﹤0.01% 1899
2015
Q1
$395K Sell
153,615
-148
-0.1% -$381 ﹤0.01% 1684
2014
Q4
$221K Hold
153,763
﹤0.01% 2347
2014
Q3
$235K Buy
153,763
+44,106
+40% +$67.4K ﹤0.01% 2261
2014
Q2
$372K Sell
109,657
-37,733
-26% -$128K ﹤0.01% 2053
2014
Q1
$522K Sell
147,390
-2,879
-2% -$10.2K ﹤0.01% 1777
2013
Q4
$921K Hold
150,269
0.01% 1381
2013
Q3
$875K Buy
150,269
+15,542
+12% +$90.5K 0.01% 1359
2013
Q2
$612K Buy
+134,727
New +$612K ﹤0.01% 1564